$EYEN
EYENOVIA, INC.

2021 Form 10-K Financial Statement

#000141057822000649 Filed on March 30, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $14.00M $2.000M $2.000M
YoY Change 600.0%
Cost Of Revenue $1.600M $800.0K $800.0K
YoY Change 100.0%
Gross Profit $12.40M $1.200M $1.200M
YoY Change 933.33%
Gross Profit Margin 88.57% 60.0% 60.0%
Selling, General & Admin $10.78M $2.060M $7.700M
YoY Change 40.05% 5.1% 6.94%
% of Gross Profit 86.97% 171.67% 641.67%
Research & Development $14.51M $3.350M $13.36M
YoY Change 8.58% 0.9% -5.16%
% of Gross Profit 117.01% 279.17% 1113.6%
Depreciation & Amortization $221.6K $30.00K $95.42K
YoY Change 132.21% 200.0% 377.08%
% of Gross Profit 1.79% 2.5% 7.95%
Operating Expenses $25.30M $5.410M $20.99M
YoY Change 20.56% 2.27% -1.51%
Operating Profit -$12.90M -$4.210M -$19.79M
YoY Change -34.79%
Interest Expense $387.8K $0.00 $17.04K
YoY Change 2175.3% -100.0% -88.64%
% of Operating Profit
Other Income/Expense, Net $47.18K $0.00 $10.00K
YoY Change 371.83%
Pretax Income -$12.78M -$4.210M -$19.77M
YoY Change -35.36% -19.66% -6.57%
Income Tax
% Of Pretax Income
Net Earnings -$12.80M -$4.210M -$19.80M
YoY Change -35.35% -19.66% -6.43%
Net Earnings / Revenue -91.43% -210.5% -990.0%
Basic Earnings Per Share -$0.49 -$0.94
Diluted Earnings Per Share -$0.49 -$169.7K -$0.94
COMMON SHARES
Basic Shares Outstanding 26.32M 21.05M
Diluted Shares Outstanding 26.32M 21.05M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.46M $28.37M $28.37M
YoY Change -31.4% 100.49% 100.49%
Cash & Equivalents $28.37M
Short-Term Investments
Other Short-Term Assets $8.266M $1.900M $1.900M
YoY Change 335.06% 1800.0% 1800.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.88M $33.39M $33.39M
YoY Change -10.52% 132.69% 132.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.271M $396.4K $400.0K
YoY Change 217.81% 72.34% 73.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $511.0K $120.0K $120.0K
YoY Change 325.82% 0.0% 0.0%
Total Long-Term Assets $1.782M $515.4K $520.0K
YoY Change 242.73% 47.26% 48.57%
TOTAL ASSETS
Total Short-Term Assets $29.88M $33.39M $33.39M
Total Long-Term Assets $1.782M $515.4K $520.0K
Total Assets $31.66M $33.91M $33.91M
YoY Change -6.64% 130.66% 130.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.614M $1.462M $1.460M
YoY Change 10.55% -5.09% -5.19%
Accrued Expenses $2.327M $2.580M $2.580M
YoY Change -9.81% 96.95% 96.95%
Deferred Revenue $14.00M
YoY Change
Short-Term Debt $0.00 $100.0K $100.0K
YoY Change -100.0%
Long-Term Debt Due $7.150M $100.0K $100.0K
YoY Change 7050.37%
Total Short-Term Liabilities $11.17M $18.20M $18.20M
YoY Change -38.61% 525.37% 525.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $370.0K $370.0K
YoY Change -100.0%
Other Long-Term Liabilities $19.95K $40.00K $40.00K
YoY Change -50.13% -20.0% -20.0%
Total Long-Term Liabilities $19.95K $410.0K $410.0K
YoY Change -95.13% 720.0% 720.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.17M $18.20M $18.20M
Total Long-Term Liabilities $19.95K $410.0K $410.0K
Total Liabilities $11.19M $18.60M $18.60M
YoY Change -39.83% 528.48% 528.38%
SHAREHOLDERS EQUITY
Retained Earnings -$77.44M
YoY Change
Common Stock $2.498K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.47M $15.30M $15.30M
YoY Change
Total Liabilities & Shareholders Equity $31.66M $33.91M $33.91M
YoY Change -6.64% 130.66% 130.68%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$12.80M -$4.210M -$19.80M
YoY Change -35.35% -19.66% -6.43%
Depreciation, Depletion And Amortization $221.6K $30.00K $95.42K
YoY Change 132.21% 200.0% 377.08%
Cash From Operating Activities -$20.90M $5.470M -$6.400M
YoY Change 226.56% -236.07% -66.17%
INVESTING ACTIVITIES
Capital Expenditures $1.227M -$60.00K $261.3K
YoY Change 369.49% -53.85% -253.68%
Acquisitions
YoY Change
Other Investing Activities -$391.9K
YoY Change
Cash From Investing Activities -$1.619M -$60.00K -$261.3K
YoY Change 519.51% -53.85% 53.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $66.62K $0.00
YoY Change
Cash From Financing Activities 21.46M 90.00K 20.86M
YoY Change 2.84% 54.44%
NET CHANGE
Cash From Operating Activities -20.90M 5.470M -6.400M
Cash From Investing Activities -1.619M -60.00K -261.3K
Cash From Financing Activities 21.46M 90.00K 20.86M
Net Change In Cash -1.035M 5.500M 14.22M
YoY Change -107.28% -232.53% -354.82%
FREE CASH FLOW
Cash From Operating Activities -$20.90M $5.470M -$6.400M
Capital Expenditures $1.227M -$60.00K $261.3K
Free Cash Flow -$22.13M $5.530M -$6.661M
YoY Change 232.17% -242.16% -64.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26324081
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21054706
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28426616
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24978585
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001682639
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38365
CY2021 dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1178401
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
295 Madison Avenue
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2400
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2021 dei City Area Code
CityAreaCode
917
CY2021 dei Local Phone Number
LocalPhoneNumber
289-1117
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 Par Value
CY2021 dei Trading Symbol
TradingSymbol
EYEN
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453478
CY2021Q4 us-gaap Assets Current
AssetsCurrent
22001857
CY2020Q4 us-gaap Assets Current
AssetsCurrent
33391345
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Auditor Firm
AuditorFirmId
688
CY2021 dei Auditor Name
AuditorName
Marcum LLP
CY2021 dei Auditor Location
AuditorLocation
New York, NY
CY2021Q2 dei Entity Public Float
EntityPublicFloat
112773303
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31698424
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19461850
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28371828
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1600000
CY2021Q4 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
1805065
CY2020Q4 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
2966039
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
734942
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7875000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1271225
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
396380
CY2021Q4 eyen Security And Equipment Deposits
SecurityAndEquipmentDeposits
510976
CY2020Q4 eyen Security And Equipment Deposits
SecurityAndEquipmentDeposits
119035
CY2021Q4 us-gaap Assets
Assets
31659058
CY2020Q4 us-gaap Assets
Assets
33906760
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1614104
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1461665
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1543618
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1150672
CY2021Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
845719
CY2020Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
1480692
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
18685
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
7809
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14000000
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7150368
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
97539
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11172494
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18198377
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
19949
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
38684
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
365814
CY2021Q4 us-gaap Liabilities
Liabilities
11192443
CY2020Q4 us-gaap Liabilities
Liabilities
18602875
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28426616
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24978585
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2844
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2498
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110683077
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92742306
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90219306
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77440919
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31659058
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33906760
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14000000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1600000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
800000
CY2021 us-gaap Gross Profit
GrossProfit
12400000
CY2020 us-gaap Gross Profit
GrossProfit
1200000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14509525
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13363251
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10794158
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7625974
CY2021 us-gaap Operating Expenses
OperatingExpenses
25303683
CY2020 us-gaap Operating Expenses
OperatingExpenses
20989225
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-12903683
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-19789225
CY2020 eyen Small Business Administration Economic Injury Disaster Grant
SmallBusinessAdministrationEconomicInjuryDisasterGrant
10000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
463353
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47183
CY2021 us-gaap Interest Expense
InterestExpense
387756
CY2020 us-gaap Interest Expense
InterestExpense
17042
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2516
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
26400
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12778387
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19769867
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26324081
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21054706
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11740607
CY2020 eyen Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
5451742
CY2020 eyen Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
12495708
CY2020 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2820362
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
82161
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2483172
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19769867
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021 eyen Stock Issued At Market Offering During Period Value New Issues
StockIssuedAtMarketOfferingDuringPeriodValueNewIssues
12401919
CY2021 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2124904
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203126
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-26324
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
351390
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2886102
CY2021 eyen Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12778387
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
354539
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3149
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12778387
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19769867
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2886102
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2483172
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
221563
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95415
CY2021 eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
68376
CY2020 eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
463353
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 eyen Expense Reimbursement
ExpenseReimbursement
51588
CY2020 eyen Expense Reimbursement
ExpenseReimbursement
0
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55194
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-423896
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-218418
CY2021 eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-1397924
CY2020 eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
2966039
CY2021 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-1600000
CY2020 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1600000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
126115
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-79693
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
392946
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
233799
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-634973
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1000612
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14000000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
14000000
CY2021 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0
CY2020 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-1235
CY2021 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-7859
CY2020 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1142
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20874432
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6384276
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1226576
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
261257
CY2021 eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
391941
CY2020 eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1618517
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261257
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5569136
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
12734002
CY2021 eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
-12401919
CY2020 eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
0
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2124904
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2820362
CY2021 eyen Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
0
CY2020 eyen Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
463353
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7500000
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
705360
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
475216
CY2021 eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
0
CY2020 eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
329038
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
66618
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
203126
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82161
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21457971
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20864760
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1034978
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14219227
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14152601
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27336850
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19461850
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28371828
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7875000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27336850
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2021 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
227171
CY2020 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
13974
CY2021 eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
705360
CY2021 eyen Shares Withheld From Option Exercise For Employee Tax Liability
SharesWithheldFromOptionExerciseForEmployeeTaxLiability
26324
CY2021 eyen Issuance Of Common Stock Related To Vested Restricted Stock Units
IssuanceOfCommonStockRelatedToVestedRestrictedStockUnits
2
CY2021 eyen Warrants Issued For Debt Issuance Costs
WarrantsIssuedForDebtIssuanceCosts
351390
CY2021 eyen Percentage Of Success Rate Of Optejet
PercentageOfSuccessRateOfOptejet
0.90
CY2021 eyen Percentage Of Successful Rate Of Traditional Eye Drops
PercentageOfSuccessfulRateOfTraditionalEyeDrops
0.50
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19500000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90200000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12800000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19800000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20900000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6400000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and the amounts disclosed in the related notes to the financial statements. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, fair value calculations for equity securities, establishment of valuation allowances for deferred tax assets, revenue recognition, the recoverability and useful lives of long-lived assets, the recovery of deferred costs and the deferral of revenues. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 2 - Summary of Significant Accounting Policies — Stock-Based Compensation for additional discussion of the use of estimates in estimating the fair value of the Company’s common stock. </p>
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</p>
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7875000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19211850
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
28121828
CY2021 eyen Percentage Of Royalty To Be Transferred Range1
PercentageOfRoyaltyToBeTransferredRange1
0.30
CY2021 eyen Percentage Of Royalty To Be Transferred Range2
PercentageOfRoyaltyToBeTransferredRange2
0.40
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5636891
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5543101
CY2021Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
343785
CY2020Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
151942
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
171370
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
110094
CY2021Q4 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
71375
CY2020Q4 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
0
CY2021Q4 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
66250
CY2020Q4 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
68250
CY2021Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
32797
CY2020Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
0
CY2021Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
32254
CY2020Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
25004
CY2021Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
12586
CY2020Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
29403
CY2021Q4 us-gaap Other Assets
OtherAssets
4525
CY2020Q4 us-gaap Other Assets
OtherAssets
11734
CY2021Q4 eyen Prepaid Licenses And Subscriptions
PrepaidLicensesAndSubscriptions
0
CY2020Q4 eyen Prepaid Licenses And Subscriptions
PrepaidLicensesAndSubscriptions
57051
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
734942
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453478
CY2020Q4 eyen Credit Card Payable
CreditCardPayable
50002
CY2021Q4 eyen Accrued Franchise Tax
AccruedFranchiseTax
1680
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1599633
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
573286
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
328408
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
176906
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1271225
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
396380
CY2021Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
436840
CY2020Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
348254
CY2021Q4 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
250000
CY2020Q4 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
235355
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
94792
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3068
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42407
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1627
CY2021Q4 eyen Credit Card Payable
CreditCardPayable
20000
CY2020Q4 eyen Accrued Franchise Tax
AccruedFranchiseTax
32480
CY2021Q4 eyen Accrued Licensing Fees
AccruedLicensingFees
0
CY2020Q4 eyen Accrued Licensing Fees
AccruedLicensingFees
804447
CY2021Q4 eyen Accrued Expense Reimbursements
AccruedExpenseReimbursements
0
CY2020Q4 eyen Accrued Expense Reimbursements
AccruedExpenseReimbursements
5459
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
845719
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1480692
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1245795
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
938873
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
297823
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
211799
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1543618
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1150672
CY2021Q4 us-gaap Notes Payable
NotesPayable
7500000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
349632
CY2021Q4 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
7150368
CY2020Q4 us-gaap Notes Payable
NotesPayable
463353
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0
CY2020Q4 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
463353
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2021Q4 eyen Notes Payable Non Current Net Of Debt Discount Non Current Non Current Portion
NotesPayableNonCurrentNetOfDebtDiscountNonCurrentNonCurrentPortion
0
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
365814
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2020Q4 eyen Notes Payable Non Current Net Of Debt Discount Non Current Non Current Portion
NotesPayableNonCurrentNetOfDebtDiscountNonCurrentNonCurrentPortion
365814
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1248043
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3797052
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2358623
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-434082
CY2021 eyen Deferred Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance
-3606666
CY2020 eyen Deferred Income Tax Expense Benefit Before Adjustments For Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitBeforeAdjustmentsForChangeInValuationAllowance
-4231134
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3606666
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4231134
CY2021 eyen Effective Income Tax Rate Reconciliation Net At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationNetAtFederalStatutoryIncomeTaxRate
-0.210
CY2020 eyen Effective Income Tax Rate Reconciliation Net At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationNetAtFederalStatutoryIncomeTaxRate
-0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.073
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.043
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.006
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.038
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.282
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.214
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12972865
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2070759
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1385554
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
531454
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
409705
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
605919
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1861938
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20623620
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17415488
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16630062
CY2021Q4 eyen Deferred Tax Assets Liability Property And Equipment
DeferredTaxAssetsLiabilityPropertyAndEquipment
463442
CY2020Q4 eyen Deferred Tax Assets Liability Property And Equipment
DeferredTaxAssetsLiabilityPropertyAndEquipment
76550
CY2021Q4 eyen Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
20160178
CY2020Q4 eyen Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
16553512
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20160178
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16553512
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
72000000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
10800000
CY2021 eyen Operating Loss Carry Forwards Expiration Term
OperatingLossCarryForwardsExpirationTerm
2034 to 2037
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
61200000
CY2021Q4 eyen Net Operating Loss Limit For Utilization As Per Internal Revenue Code
NetOperatingLossLimitForUtilizationAsPerInternalRevenueCode
35000000
CY2021Q4 eyen Net Operating Loss Annual Utilization Limit As Per Internal Revenue Code
NetOperatingLossAnnualUtilizationLimitAsPerInternalRevenueCode
918000
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Severance Costs1
SeveranceCosts1
332750
CY2021Q4 us-gaap Supplemental Unemployment Benefits Salary Continuation
SupplementalUnemploymentBenefitsSalaryContinuation
1331000
CY2018Q3 us-gaap Net Rentable Area
NetRentableArea
3800
CY2018Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-09-30
CY2018Q3 us-gaap Security Deposit
SecurityDeposit
119000
CY2020Q1 us-gaap Net Rentable Area
NetRentableArea
660
CY2020Q1 eyen Lease Monthly Base Rent
LeaseMonthlyBaseRent
1234
CY2020Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
CY2020Q3 us-gaap Net Rentable Area
NetRentableArea
3000
CY2020Q3 eyen Lease Monthly Base Rent
LeaseMonthlyBaseRent
7500
CY2020Q3 us-gaap Security Deposit
SecurityDeposit
7500
CY2020Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-08-31
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2011313
CY2020Q2 eyen Percentage Of Royalty To Be Transferred Range1
PercentageOfRoyaltyToBeTransferredRange1
0.30
CY2020Q2 eyen Percentage Of Royalty To Be Transferred Range2
PercentageOfRoyaltyToBeTransferredRange2
0.40
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
464452
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
331442
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
795894
CY2020Q2 eyen Percentage Of Royalty To Be Transferred Range2
PercentageOfRoyaltyToBeTransferredRange2
0.40
CY2020Q4 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.43
CY2021 eyen Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
91884
CY2021 eyen Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
4.76
CY2021 eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
-885482
CY2021 eyen Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
2.40
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1217715
CY2021Q4 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.69
CY2021 eyen Class Of Warrant Or Right Outstanding Weighted Average Remaining Life
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingLife
P3Y8M12D
CY2021Q4 eyen Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
1667925
CY2021Q4 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1217715
CY2021Q4 eyen Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
2.69
CY2021 eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y8M12D
CY2021Q4 eyen Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value
ClassOfWarrantOrRightExercisableAggregateIntrinsicValue
1667925
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1217715
CY2021 eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y8M12D
CY2021Q4 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1217715
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
885482
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2100000
CY2020Q1 eyen Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
5450000
CY2020Q1 eyen Placement Agent Fees And Offering Expenses
PlacementAgentFeesAndOfferingExpenses
530000
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2675293
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2886102
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2483172
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
104083
CY2020Q4 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
3.84
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
49964
CY2021 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
3.59
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
105306
CY2021 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
3.86
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6963
CY2021 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
3.59
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41778
CY2021Q4 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
3.59
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
121261
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.39
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.01
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4377398
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2525368
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5260000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2019Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2019Q2 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.04
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
175352
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
138785

Files In Submission

Name View Source Status
0001410578-22-000649-index-headers.html Edgar Link pending
0001410578-22-000649-index.html Edgar Link pending
0001410578-22-000649.txt Edgar Link pending
0001410578-22-000649-xbrl.zip Edgar Link pending
eyen-20211231.xsd Edgar Link pending
eyen-20211231x10k.htm Edgar Link pending
eyen-20211231x10k002.jpg Edgar Link pending
eyen-20211231x10k003.jpg Edgar Link pending
eyen-20211231x10k004.jpg Edgar Link pending
eyen-20211231x10k006.jpg Edgar Link pending
eyen-20211231x10k007.jpg Edgar Link pending
eyen-20211231x10k008.jpg Edgar Link pending
eyen-20211231x10k009.jpg Edgar Link pending
eyen-20211231x10k010.jpg Edgar Link pending
eyen-20211231x10k011.jpg Edgar Link pending
eyen-20211231x10k012.jpg Edgar Link pending
eyen-20211231x10k013.jpg Edgar Link pending
eyen-20211231x10k014.jpg Edgar Link pending
eyen-20211231x10k015.jpg Edgar Link pending
eyen-20211231x10k016.jpg Edgar Link pending
eyen-20211231x10k017.jpg Edgar Link pending
eyen-20211231x10k018.jpg Edgar Link pending
eyen-20211231x10k019.jpg Edgar Link pending
eyen-20211231x10k_htm.xml Edgar Link completed
eyen-20211231xex10d22.htm Edgar Link pending
eyen-20211231xex10d23.htm Edgar Link pending
eyen-20211231xex10d24.htm Edgar Link pending
eyen-20211231xex10d25.htm Edgar Link pending
eyen-20211231xex23d1.htm Edgar Link pending
eyen-20211231xex31d1.htm Edgar Link pending
eyen-20211231xex31d2.htm Edgar Link pending
eyen-20211231xex32d1.htm Edgar Link pending
eyen-20211231xex32d2.htm Edgar Link pending
eyen-20211231xex4d1.htm Edgar Link pending
eyen-20211231_cal.xml Edgar Link unprocessable
eyen-20211231_def.xml Edgar Link unprocessable
eyen-20211231_lab.xml Edgar Link unprocessable
eyen-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending